Imperial partner Apollo receives £100m to boost medical research at leading unis
Imperial will benefit from continued support for translational biomedical research under a unique technology transfer model.
Podcast explores new frontiers in analytical science
A new podcast from Agilent and Imperial features analytical scientists who are working on a variety of real-world questions and challenges.
Key enzyme aggravates colorectal cancer in obese patients
New research suggests the enzyme CES1 helps tumour cells to survive and drives aggressive colorectal cancer in obese patients.
New study reveals weak spots in chemotherapy-resistant cancer cells
Molecular ‘weak spots' in cancer cells recovering from chemotherapy could provide the basis for better treatments, according to new research
Cancer drugs could be delivered in molecular cages unlocked by light
Molecular cages created by Imperial researchers could lead to more targeted cancer drug delivery, causing greater efficiency and fewer side effects.
ADC Therapeutics to develop anti-cancer drugs in new White City Campus centre
Biotechnology company ADC Therapeutics is to launch a new research centre in Imperial’s White City Campus to develop next-generation cancer drugs.
Video
Imperial staff reflect on a challenging year – and their hopes for the future
In a new video, Imperial staff at the heart of the COVID-19 response share their thoughts on the challenges of 2020 – and hopes for the future.
Imperial set to lead UK trial of innovative new cancer drug
The trial will assess a promising new drug developed by Imperial scientists, designed to treat multiple myeloma and diffuse large b-cell lymphoma.
2
Imperial startup wins £4.5m investment to develop new cancer drugs
An Imperial startup has won £4.5m investment to develop drugs that could offer a safer and more effective way to treat certain drug-resistant cancers.
3
Molecular insights into key drug target could help to enhance cancer treatments
New research reveals how a key protein in cells could be tweaked to make cancer treatments more effective.
